Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosis is a research paper published in Contemporary Clinical Trials Communications (2020). On theSindex it has a DataRank of 0.373. It has been cited 9 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.0279
From 4 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
National Institutes of Health
Grant: 5UL1TR001070-02
The Ohio State University Center for clinical and Translational Science
National Institutes of Health
Grant: 5R34HL123586-03
Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study
National Center for Advancing Translational Sciences
National Institutes of Health
FWCI
0.90
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals